Literature DB >> 17061173

Abdominal sacral resection for posterior pelvic recurrence of rectal carcinoma: analyses of prognostic factors and recurrence patterns.

Takayuki Akasu1, Takashi Yamaguchi, Yoshiya Fujimoto, Seiji Ishiguro, Seiichiro Yamamoto, Shin Fujita, Yoshihiro Moriya.   

Abstract

BACKGROUND: Local recurrence of rectal cancer presents challenging problems. Although abdominal sacral resection (ASR) provides pain control, survival prolongation, and possibly cure, reported morbidity and mortality are still high, and survival is still low. Thus, appropriate patient selection and adjuvant therapy based on prognostic factors and recurrence patterns are necessary. The purpose of this study was to evaluate the results of ASR for posterior pelvic recurrence of rectal carcinoma and to analyze prognostic factors and recurrence patterns.
METHODS: Forty-four patients underwent ASR for curative intent in 40 and palliative intent in 4 cases. All but one could be followed up completely. Multivariate analyses of factors influencing survival and positive surgical margins were conducted.
RESULTS: Morbidity and mortality were 61% and 2%, respectively. Overall 5-year survival was 34%. The Cox regression model revealed a positive resection margin (hazard ratio, 10 [95% confidence interval, 3.8-28]), a local disease-free interval of <12 months (4.2 [1.8-9.8]), and pain radiating to the buttock or further (4.2 [1.6-11]) to be independently associated with poor survival. The logistic regression model showed that macroscopic multiple expanding or diffuse infiltrating growths were independently associated with a positive margin (7.5 [1.4-40]). Of the patients with recurrence, 56% had failures confined locally or to the lung.
CONCLUSIONS: ASR is beneficial to selected patients in terms of survival. To select patients, evaluation of the resection margin, the local disease-free interval, pain extent, and macroscopic growth pattern is important. To improve survival, adjuvant treatment should be aimed at local and lung recurrences.

Entities:  

Mesh:

Year:  2006        PMID: 17061173     DOI: 10.1245/s10434-006-9082-0

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  10 in total

Review 1.  Management of metastatic sacral tumours.

Authors:  Nasir A Quraishi; Kyriakos E Giannoulis; Kimberley L Edwards; Bronek M Boszczyk
Journal:  Eur Spine J       Date:  2012-06-23       Impact factor: 3.134

Review 2.  Intraoperative radiotherapy in colorectal cancer: systematic review and meta-analysis of techniques, long-term outcomes, and complications.

Authors:  Reza Mirnezami; George J Chang; Prajnan Das; Kandiah Chandrakumaran; Paris Tekkis; Ara Darzi; Alexander H Mirnezami
Journal:  Surg Oncol       Date:  2012-12-25       Impact factor: 3.279

Review 3.  Stereotactic body radiotherapy for oligo-recurrence within the nodal area from colorectal cancer.

Authors:  Young Seok Seo; Mi-Sook Kim; Hyung-Jun Yoo; Won-Il Jang
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

4.  Prognostic factors affecting oncologic outcomes in patients with locally recurrent rectal cancer: impact of patterns of pelvic recurrence on curative resection.

Authors:  Jea-Kun Park; Young-Wan Kim; Hyuk Hur; Nam-Kyu Kim; Byung-Soh Min; Seung-Kook Sohn; Young-Deuk Choi; Young-Tae Kim; Jung-Bai Ahn; Jae-Kyung Roh; Ki-Chang Keum; Jin-Sil Seong
Journal:  Langenbecks Arch Surg       Date:  2008-07-29       Impact factor: 3.445

5.  How uncommon are isolated lung metastases in colorectal cancer? A review from database of 754 patients over 4 years.

Authors:  Ker Kan Tan; Gilberto de Lima Lopes; Richard Sim
Journal:  J Gastrointest Surg       Date:  2008-12-11       Impact factor: 3.452

6.  Post operative stereotactic radiosurgery for positive or close margins after preoperative chemoradiation and surgery for rectal cancer.

Authors:  Nergiz Dagoglu; Elena Nedea; Vitaliy Poylin; Deborah Nagle; Anand Mahadevan
Journal:  J Gastrointest Oncol       Date:  2016-06

7.  Clinical presentation, management and outcomes of sacral metastases: a multicenter, retrospective cohort study.

Authors:  Raphaële Charest-Morin; Charles G Fisher; Ann L Versteeg; Arjun Sahgal; Peter Pal Varga; Daniel M Sciubba; James M Schuster; Michael H Weber; Michelle J Clarke; Laurence D Rhines; Stefano Boriani; Chetan Bettegowda; Michael G Fehlings; Paul M Arnold; Ziya L Gokaslan; Nicolas Dea
Journal:  Ann Transl Med       Date:  2019-05

8.  Abdominosacral resection for locally recurring rectal cancer.

Authors:  Filiberto Belli; Alessandro Gronchi; Carlo Corbellini; Massimo Milione; Ermanno Leo
Journal:  World J Gastrointest Surg       Date:  2016-12-27

9.  Institutional analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lymph node metastases.

Authors:  Rosanna Yeung; Jeremy Hamm; Mitchell Liu; Devin Schellenberg
Journal:  Radiat Oncol       Date:  2017-06-21       Impact factor: 3.481

10.  Critical evaluation of contemporary management in a new Pelvic Exenteration Unit: The first 25 consecutive cases.

Authors:  Min Hoe Chew; Yu-Ting Yeh; Ee-Lin Toh; Stephen Aditya Sumarli; Ghee Kheng Chew; Lui Shiong Lee; Mann Hong Tan; Tiffany Priyanthi Hennedige; Shin Yi Ng; Say Kiat Lee; Tze Tec Chong; Hairil Rizal Abdullah; Terence Lin Hon Goh; Mohamed Zulfikar Rasheed; Kok Chai Tan; Choong Leong Tang
Journal:  World J Gastrointest Oncol       Date:  2017-05-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.